Atlas Venture Fund X, L.P.

Insider Buys Quantity –
0
2024-03-13SaleKymera Therapeutics, Inc.
KYMR
10 percent owner
139,255
0.2271%
$42.23$5.88M-16.65%
2024-03-12SaleKymera Therapeutics, Inc.
KYMR
10 percent owner
162,918
0.2674%
$41.98$6.84M-15.72%
2024-03-11SaleKymera Therapeutics, Inc.
KYMR
10 percent owner
51,184
0.0849%
$42.85$2.19M-16.61%
2023-01-12SaleKymera Therapeutics, Inc.
KYMR
director
98,720
0.153%
$30.29$2.99M-26.07%
2023-01-11SaleKymera Therapeutics, Inc.
KYMR
director
27,754
0.0478%
$29.96$831,510-16.97%
2022-12-15SaleKymera Therapeutics, Inc.
KYMR
director
3,278
0.0061%
$30.00$98,340-11.97%
2022-12-14SaleKymera Therapeutics, Inc.
KYMR
director
378,966
0.6933%
$31.37$11.89M-17.08%
2022-11-03SaleKymera Therapeutics, Inc.
KYMR
director
96,397
0.1616%
$30.00$2.89M-11%
2022-11-02SaleKymera Therapeutics, Inc.
KYMR
director
123,619
0.223%
$30.02$3.71M-4.24%
2022-11-01SaleKymera Therapeutics, Inc.
KYMR
director
77,030
0.136%
$30.60$2.36M-7.8%
2022-10-31SaleKymera Therapeutics, Inc.
KYMR
director
120,622
0.2076%
$30.23$3.65M-8.7%
2022-10-28SaleKymera Therapeutics, Inc.
KYMR
director
91,050
0.1573%
$30.00$2.73M-7.5%